Cargando…
Synthesis of the calcilytic ligand NPS 2143
(R)-3 (NPS 2143) is a negative allosteric modulator of the human calcium-sensing receptor (CaSR) and as such represents an important pharmacological tool compound for studying the CaSR. Herein, we disclose for the first time a complete experimental description, detailed characterisation and assessme...
Autores principales: | Johansson, Henrik, Cailly, Thomas, Rojas Bie Thomsen, Alex, Bräuner-Osborne, Hans, Sejer Pedersen, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740522/ https://www.ncbi.nlm.nih.gov/pubmed/23946832 http://dx.doi.org/10.3762/bjoc.9.154 |
Ejemplares similares
-
The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca(2+) channels
por: Greenberg, Harry Z.E., et al.
Publicado: (2016) -
Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin-angiotensin system
por: Zhao, Yongli, et al.
Publicado: (2020) -
Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy
por: Chiarini, Anna, et al.
Publicado: (2017) -
Calcilytic NPS 2143 Reduces Amyloid Secretion and Increases sAβPPα Release from PSEN1 Mutant iPSC-Derived Neurons
por: Lo Giudice, Maria, et al.
Publicado: (2019) -
The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Hannan, Fadil M., et al.
Publicado: (2015)